A Cost-Effectiveness Analysis of Secukinumab 300 Mg Vs Current Therapies for The Treatment of Moderate to Severe Plaque Psoriasis In Italy

Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.574
https://www.valueinhealthjournal.com/article/S1098-3015(15)02650-9/fulltext
Title : A Cost-Effectiveness Analysis of Secukinumab 300 Mg Vs Current Therapies for The Treatment of Moderate to Severe Plaque Psoriasis In Italy
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02650-9&doi=10.1016/j.jval.2015.09.574
First page : A424
Section Title : Research Podium Presentations - Session 1 and Session 2
Open access? : No
Section Order : 494
Categories :
Tags :
Regions :
ViH Article Tags :